18.04.2019 - Shifa International

OUT-PATIENT
www.shifa.com.pk
MR No............... : 19-41-08-74
Patient............... : Mrs. Ameer Begum
Age/Gender....... : 55 Yrs 00 Months 09 Days /Female
Ordered By........ : Dr. Self - 01P
Ordered On....... : 18/04/2019 18:42
Specimen No..... : 19010155800
PATHOLOGY Received in Lab. : 18/04/2019 20:13
Chemistry Verified On....... : 20/04/2019 09:25
TEST RESULTS REFERENCE RANGE
CE07-Serum Protein Electrophoresis

TOTAL PROTEIN........................... 7.4 g/dL 6.40 - 8.30 g/dL
This is a Computer GENERATED Report. It DOES NOT require any SIGNATURE or STAMP.
ALBUMIN................................. 4.1 g/dL 3.2 - 5.5 g/dL
ALPHA 1................................. 0.1 g/dL 0.1 - 0.4 g/dL
NOT TO BE USED FOR LEGAL PURPOSE

ALPHA 2................................. 0.6 g/dL 0.4 - 1.2 g/dL
BETA.................................... 0.9 g/dL 0.5 - 1.1 g/dL
GAMMA................................... 1.7 g/dL 0.5 - 1.6 g/dL
A/G RATIO............................... 1.2 1.2 - 1.7
PGY - I I I (IMMUNOLOGY) : Dr. Shafain Sheikh (17251) PGY - I I I (IMMUNOLOGY) : Dr. Shafain Sheikh (17251)
Dr.Fazal Ilahi MD Dr.Imran Ahmad MD,FCAP Dr.Nadira Mamoon Dr.Humaira Nasir Dr.Ayesha Junaid Dr.Ghazanfar Abbas
Senior Advisor Pathology Chief Pathologist / Director Lab Associate Chief Pathologist Consultant Pathologist Consultant Haematologist Associate Consultant
D.Path Eng. D.C.P. London Assistant Professor of Consultant Pathologist Assistant Professor of Professor of Pathology Chemical Pathologist,
Diplomate Anatomical Pathology Professor of Pathology Pathology Program Director Hematology Assistant Professor of
Pathology, Diplomate Anatomic Pathology MBBS, FCPS (Histopathology, MBBS, FRC Path(U.K) MBBS,M.C.P.S (Clinical Pathology,
Clinical Pathology U.S.A and Hematology(USA) Cytopathology), FRC Path(UK) MCPS (Clinical Pathology) Pathology) MBBS, FCPS (Chemical
FCAP FASCP U.S.A. Fellow Hematopathology(USA) Ext: 3873 FCPS (Histopathology, Cytopath FCPS (Haematology) Pathology) Ext: 3640
Dr.Tahir Aziz Ahmed Dr.Asna Haroon Khan Dr.Muhammad Usman Dr.Zafar Ali Dr.Zujajah Hameed Dr.Shawana Kamran
Consultant Immunologist Consultant Histopathologist Associate Consultant Associate Consultant Associate Consultant Associate Consultant
Professor of Pathology MBBS,FCPS (Histopathology Microbiologist Histopathologist Histopathologist, Hematologist
MBBS, and Cytopathology) MBBS,FCPS(Microbiology) Assistant Professor of MBBS, FCPS (Histopathology, MBBS, FCPS(Hematology)
MCPS,FCPS(Microbiology) Ext: 4203 Ext:4283 Pathology Cytopathology) Incharge Cytogenetic
FRC Path (Immunology) MBBS, FCPS (Histopathology, Ext: 4116 Laboratory
Ext:4348 Cytopathology) Ext: 4326
Printed On : 27/04/2019 -19 12:21 Printed By AROOSA_20507

OUT-PATIENT
www.shifa.com.pk
MR No............... : 19-41-08-74
Ordered On....... : 18/04/2019 18:42
Specimen No..... : 19010155800
Verified On....... : 20/04/2019 09:25
Comments :
Serum Protein Electrophoresis :
Shows no paraproteins.
Test Methodology: Agarose Gel Electrophoresis.
(Biotech-Fischer GmbH, Reiskirchen Germany).

OUT-PATIENT
www.shifa.com.pk
MR No............... : 19-41-08-74
Ordered On....... : 18/04/2019 18:42
Specimen No..... : 0418IM00013
Immunology Verified On....... : 20/04/2019 09:25
IL19-Serum Free Light Chain (Kappa + Lambda)
TEST RESULTS REFERENCE RANGE
Free kappa.............................. 132.88 mg/L 3.3 - 19.4 mg/L
Free lambda............................. 59.9 mg/L 5.71 - 26.3 mg/L
Kappa / lambda ratio:................... 2.218 mg/L 0.26 - 1.65

Comments :
The increase in serum free light chains is likely to be due to renal dysfunction. Suggest: Repeat to monitor. In
addition, serum and urine immunofixation if investigations for possible gammopathy are indicated. (Tests
were performed using Binding Site-UK reagents with reading on SPA Plus-Binding Site).
Free light chain test forms part of diagnostic and follow up laboratory tests in patients with multiple myeloma
and other disases with monoclonal paraproteins. NCCN Guidelines version 4.2015-Multiple Myeloma.

18.04.2019 - Shifa International

Uploaded by

Copyright:

Available Formats

18.04.2019 - Shifa International

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

18.04.2019 - Shifa International

Uploaded by

Copyright:

Available Formats

OUT-PATIENT

TEST RESULTS REFERENCE RANGE

CE07-Serum Protein Electrophoresis

ALPHA 1................................. 0.1 g/dL 0.1 - 0.4 g/dL

NOT TO BE USED FOR LEGAL PURPOSE

BETA.................................... 0.9 g/dL 0.5 - 1.1 g/dL

GAMMA................................... 1.7 g/dL 0.5 - 1.6 g/dL

A/G RATIO............................... 1.2 1.2 - 1.7

Printed On : 27/04/2019 -19 12:21 Printed By AROOSA_20507

Test Methodology: Agarose Gel Electrophoresis.

NOT TO BE USED FOR LEGAL PURPOSE

Printed On : 27/04/2019 -19 12:21 Printed By AROOSA_20507

IL19-Serum Free Light Chain (Kappa + Lambda)

TEST RESULTS REFERENCE RANGE

Free kappa.............................. 132.88 mg/L 3.3 - 19.4 mg/L

Kappa / lambda ratio:................... 2.218 mg/L 0.26 - 1.65

NOT TO BE USED FOR LEGAL PURPOSE

Printed On : 27/04/2019 -19 12:21 Printed By AROOSA_20507

You might also like